Dieras, V. : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (242)
Les plus populaires
Liste
- Liste
- Tableau

51

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

P Kerbrat, V Dieras, N Pavlidis, A Ravaud, J Wanders, P Fumoleau

Journal:

European Journal of Cancer

Année:

2003

Langue:

english

Fichier:

PDF, 87 KB

english, 2003

52

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response

J.-Y Pierga, E Mouret, V Laurence, V Diéras, A Savigioni, P Beuzeboc, T Dorval, T Palangié, M Jouve, P Pouillart

Journal:

European Journal of Cancer

Année:

2003

Langue:

english

Fichier:

PDF, 277 KB

english, 2003

53

1260 POSTER Preliminary Signs of Efficacy Reported in Monotherapy Phase I Cancer Clinical Trials of Molecularly Targeted Agents and Correlation With Further Clinical Development

J. Arrondeau, X. Paoletti, S. Pop, P. Tresca, V. Dieras, C. Le Tourneau

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 61 KB

english, 2011

54

653 - Response to chemotherapy is the first prognostic factor in metastatic breast cancer

J.Y. Pierga, M. Jouve, B. Asselain, V. Diéras, P. Beuzaboc, T. Patangié, T. Dorval, E. Garcia-Giralt, S. Scholl, P. Pouillart

Journal:

European Journal of Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 221 KB

english, 1997

55

P64 Initial versus delayed radiotherapy combined with continuous 5-fluorouracile (F), cyclophosphamide (C) and doxorubicine (A) in inflammatory breast cancer (IBC)

T. Palangie, B. Asselain, F. Campana, P. Beuzeboc, V. Diéras, T. Dorval, M. Jouve, J.-Y. Pierga, S. Scholl, P. Pouillart

Journal:

European Journal of Cancer

Année:

1998

Langue:

english

Fichier:

PDF, 158 KB

english, 1998

56

P31 Prognostic significance of vascular tumor emboli in 1518 breast carcinoma patients with small tumor size (≤3 cm)

J.-Y. Pierga, A. Vincent-Salomon, M. Cousineau, B. Zafrani, B. Asselain, V. Diéras, X. Sastre-Garau, P. Pouillart

Journal:

European Journal of Cancer

Année:

1998

Langue:

english

Fichier:

PDF, 152 KB

english, 1998

57

Docetaxel in combination with doxorubicin or vinorelbine

V. Diéras, P. Furnoleau, S. Kalla, J.L. Misset, N. Azli, P. Pouillart

Journal:

European Journal of Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 352 KB

english, 1997

58

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

A.C Braud, B Asselain, S Scholl, A De La Rochefordière, T Palangie, V Dieras, J.Y Pierga, T Dorval, M Jouve, P Beuzeboc, P Pouillart

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 125 KB

english, 1999

59

Timing of combined chemoradiotherapy in the conservative treatment of locally advanced breast cancer (LABC)

J.Y. Pierga, F. Campana, B. Laguerre, T. Palangié, A. Fourquet, B. Asselain, V. Diéras, P. Beuzebix, T. Dorval, S. Scholl, P. Pouillart

Journal:

European Journal of Cancer

Année:

1998

Langue:

english

Fichier:

PDF, 173 KB

english, 1998

60

Is ERBB-2 A predictive marker for response to primary chemotherapy for operable breast cancer: a prospective study in a phase ii randomized trial of doxorubicin/cyclophosphamide (AC) and doxorubicin/paclitaxel (AT)

P. De Crémoux, V. Diéras, V. Le Doussal, A. Vincent-Salomon, M. Tubiana-Hulin, J.-Y. Pierga, F. Spyratos, H. Magdelénat, P. Pouillart

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 120 KB

english, 1999

61

Phase II study of sequential docetaxel (Taxotere®, TXT) and doxorubicin (Dox) as primary chemotherapy (CT) for large operable breast cancer (BC)

V. Laurence, V. Girre, J.M. Extra, V. Dieras, T. Palangie, J. Dorval, J.Y. Pierga, M. Jouve, P. Beuzeboc, P. Pouillart

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 142 KB

english, 1999

62

Neoadjuvant chemotherapy for breast cancer (BC): is doxorubicin-cyclophosphamide (AC) combination still a standard regimen?

P. Fumoleau, V. Dieras, G. Romieu, M. Tubiana-Hulin, M. Namer, L. Mauriac, J.P. Guastalla, P. Kerbrat, A. Martinez, P. Pouillart

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 307 KB

english, 1999

63

Cisplatin-docetaxel (Taxotere®) in first line treatment of advanced ovarian cancer (AOC)

V. Dieras, J.M. Ferrero, R. Kheder, B. Weber, P. Winckel, A. Lortho-lary, F. Mayer, D.J. Paraiso, E. Pujade-Lauraine

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 150 KB

english, 1999

64

Chemotherapy for metastatic breast cancer–report of a European expert panel

John Crown, Véronique Diéras, Manfred Kaufmann, Gunter von Minckwitz, Stan Kaye, Robert Leonard, Michel Marty, Jean-Louis Misset, Bruno Osterwalder, Martine Piccart

Journal:

The Lancet Oncology

Année:

2002

Langue:

english

Fichier:

PDF, 1.27 MB

english, 2002

65

Cancer du sein || Classification moléculaire des cancers du sein: vers une classification prédictive

Année:

2007

Langue:

french

Fichier:

PDF, 107 KB

french, 2007

66

Preliminary Results of Whole Brain Radiotherapy With Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients

Cyrus Chargari, Hind Riahi Idrissi, Jean-Yves Pierga, Marc A. Bollet, Véronique Diéras, François Campana, Paul Cottu, Alain Fourquet, Youlia M. Kirova

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2011

Langue:

english

Fichier:

PDF, 99 KB

english, 2011

67

Preoperative radio-chemotherapy in early breast cancer patients: Long-term results of a phase II trial

Marc A. Bollet, Lisa Belin, Fabien Reyal, François Campana, Rémi Dendale, Youlia M. Kirova, Fabienne Thibault, Véronique Diéras, Brigitte Sigal-Zafrani, Alain Fourquet

Journal:

Radiotherapy and Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 309 KB

english, 2012

68

552 Evaluation of the pharmacokinetic (PK) interactions between cetuximab and irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing advanced solid tumors. Results of a phase I study

C. Delbaldo, J.Y. Pierga, V. Dieras, S. Faivre, M. Bonnay, J.C. Vedovato, M. Mueser, A. Nolting, A. Kovar, E. Raymond

Journal:

European Journal of Cancer Supplements

Année:

2003

Langue:

english

Fichier:

PDF, 164 KB

english, 2003

69

Pathological response to preoperative concurrent chemoradiotherapy for breast cancers considered too large for initial conserving surgery: results of a phase II study

M.A. Bollet, Gambotti, B. Sigal-Zafrani, J.-M. Extra, C. Nos, R. Dendale, F. Campana, Y.M. Kirova, V. Dieras, A. Fourquet

Journal:

European Journal of Cancer Supplements

Année:

2006

Langue:

english

Fichier:

PDF, 139 KB

english, 2006

70

Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study

V. Diéras, A. Lortholary, V. Laurence, R. Delva, V. Girre, A. Livartowski, S. Assadourian, D. Semiond, J.Y. Pierga

Journal:

European Journal of Cancer

Année:

2013

Langue:

english

Fichier:

PDF, 396 KB

english, 2013

71

Pathological assessment after neoadjuvant therapy: not an easy task

A. Vincent-Salomon, M. Lae, N. Weber, P. Freneaux, B. Sigal-Zafrani, R.J. Salmon, V. Dieras, A. Fourquet, X. Sastre-Garau

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 53 KB

english, 2008

72

5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab

F. Cardoso, L. Gianni, G. Jerusalem, A. Fasolo, J. Bergh, V. Dieras, C. Manlius, P. Mukhopadhyay, C. Massacesi, T. Sahmoud

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 50 KB

english, 2009

73

5016 Efficacy in patient subgroups in RIBBON-1, a randomized, double-blind, Phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC)

V. Dieras, J. Glaspy, A. Brufsky, I. Bondarenko, O. Lipatov, E.A. Perez, S. Chan, X. Zhou, S.C. Phan, N. Robert

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 49 KB

english, 2009

74

5053 Platinum-based chemotherapy in triple-negative metastatic breast cancer: results of the Institut Curie experience

L. Staudacher, P.H. Cottu, V. Diéras, A. Vincent-Salomon, M.N. Guilhaume, L. Escalup, V. Girre, L. Mignot, J.Y. Pierga

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 46 KB

english, 2009

75

99 Concurrent whole brain radiotherapy (WBRT) and trastuzumab (T) in breast cancer (BC) patients presenting with brain metastases

H. Riahi, J.Y. Pierga, M.A. Bollet, P. Cottu, F. Campana, R. Dendale, T. Dorval, V. Dieras, A. Fourquet, Y.M. Kirova

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 46 KB

english, 2010

76

475 Consistent progression-free survival benefit of capecitabine-bevacizumab in all prespecified subgroups of the RIBBON-1 study in patients with metastatic breast cancer (MBC)

J. O'Shaughnessy, V. Dieras, S. Chan

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 44 KB

english, 2010

77

487 Efficacy of first-line capecitabine plus bevacizumab in patients with ER/PgR-positive metastatic breast cancer (MBC) and those previously treated with hormone therapy

V. Diéras, V. Semiglazov, S. Tjulandin

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 48 KB

english, 2010

78

467 Platinum-based chemotherapy in triple-negative metastatic breast cancer: results of the Institut Curie experience with cisplatinum and ifosfamide

L. Staudacher, P.H. Cottu, V. Diéras, A. Salomon, M.N. Guilaume, L. Escalup, L. Mignot, J.Y. Pierga

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 46 KB

english, 2010

79

476 PFS by patient subgroup for standard chemotherapies in combination with bevacizumab (BV) in the first-line treatment of HER2-negative locally recurrent (LR) or metastatic breast cancer (mBC): results from RIBBON-1

I. Bondarenko, J. Glaspy, A. Brufsky, O. Lipatov, E.A. Perez, S. Chan, X. Zou, S.C. Phan, N.J. Robert, V. Dieras

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 45 KB

english, 2010

80

469 Incidence of selected adverse events (AEs) in phase III studies of bevacizumab (BV) in combination with chemotherapy for the treatment of HER2-negative metastatic breast cancer (mBC)

D.W. Miles, V. Dieras, J. Glaspy, A. Brufsky, P. Koralewski, S.C. Phan, N.J. Robert

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 49 KB

english, 2010

81

490 Long term survival and incidence of brain metastasis in HER2- positive (HER2+) metastatic breast cancer patients (MBC) treated with trastuzumab (T): an institutional based review

V. Diéras, M.N. Guilhaume, M. Fall, J.Y. Pierga, P. Beuzeboc, P. Cottu, C. Simondi, M. Courbard, M. Mignot, A. Livartowski

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 66 KB

english, 2010

82

489 Bevacizumab (BV) in combination with chemotherapy in the treatment of HER2-negative metastatic breast cancer (mBC): PFS subgroup results from two phase III studies

J. Glaspy, V. Dieras, A. Brufsky, D.W. Miles, S.C. Phan, J. O'Shaughnessy

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 48 KB

english, 2010

83

148 In vivo preclinical evaluation of the topoisomerase I inhibitor camptothecin in human triple negative breast cancer xenografts

F. Némati, V. Diéras, L. de Plater, A. Berniard, F. Assayag, C. Elbaz, J.J. Fontaine, A. Vincent-Salomon, E. Marangoni, D. Decaudin

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 45 KB

english, 2010

84

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone, Véronique Diéras, Claire Cropet, Florence Dalenc, Marta Jimenez, Emilie Le Rhun, Jean-Yves Pierga, Anthony Gonçalves, Marianne Leheurteur, Julien Domont,

Journal:

The Lancet Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 267 KB

english, 2013

85

Brain metastases from HER2-positive breast cancer – Authors' reply

Thomas Bachelot, Claire Cropet, Véronique Diéras, Marta Jimenez, Mario Campone

Journal:

The Lancet Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 41 KB

english, 2013

86

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Verma, Sunil, Miles, David, Gianni, Luca, Krop, Ian E., Welslau, Manfred, Baselga, José, Pegram, Mark, Oh, Do-Youn, Diéras, Véronique, Guardino, Ellie, Fang, Liang, Lu, Michael W., Olsen, Steven, Blac

Journal:

Boston Medical and Surgical Journal

Année:

2012

Langue:

english

Fichier:

PDF, 365 KB

english, 2012

87

Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

Bojana Milojkovic Kerklaan, Veronique Diéras…

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2013

Langue:

english

Fichier:

PDF, 95 KB

english, 2013

88

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

Bojana Milojkovic Kerklaan, Veronique Diéras…

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2013

Langue:

english

Fichier:

PDF, 262 KB

english, 2013

89

The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer

Véronique Diéras, Thomas Bachelot

Journal:

Targeted Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 419 KB

english, 2014

90

Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial

Lise Roca, Véronique Diéras, Henri Roché, Emmanuelle Lappartient, Pierre Kerbrat, Laurent Cany, Stéphanie Chieze, Jean-Luc Canon, Marc Spielmann, Frédérique Penault-Llorca, Anne-Laure Martin, Christel

Journal:

Breast Cancer Research and Treatment

Année:

2013

Langue:

english

Fichier:

PDF, 253 KB

english, 2013

91

Docetaxel and ovarian cancer

Cottu, Paul H, Mignot, Laurent, Diéras, Véronique

Journal:

Expert Review of Obstetrics & Gynecology

Année:

2007

Langue:

english

Fichier:

PDF, 78 KB

english, 2007

92

First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients

Miles, D. W., Dieras, V., Cortes, J., Duenne, A.- A., Yi, J., O'Shaughnessy, J.

Journal:

Annals of Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 426 KB

english, 2013

93

Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer

Crown, J. P., Dieras, V., Staroslawska, E., Yardley, D. A., Bachelot, T., Davidson, N., Wildiers, H., Fasching, P. A., Capitain, O., Ramos, M., Greil, R., Cognetti, F., Fountzilas, G., Blasinska-Moraw

Journal:

Journal of Clinical Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 192 KB

english, 2013

94

[IEEE 2008 Canadian Conference on Electrical and Computer Engineering - CCECE - Niagara Falls, ON, Canada (2008.05.4-2008.05.7)] 2008 Canadian Conference on Electrical and Computer Engineering - Efficiency competition on N-queen problem: DE vs. CMA-ES

Rahnamayan, Shahryar, Dieras, Paul

Année:

2008

Langue:

english

Fichier:

PDF, 113 KB

english, 2008

95

Expert perspectives on biosimilar monoclonal antibodies in breast cancer

Cortés, J., Curigliano, G., Diéras, V.

Journal:

Breast Cancer Research and Treatment

Année:

2014

Langue:

english

Fichier:

PDF, 203 KB

english, 2014

96

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Lin, N. U., Dieras, V., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H.-J., Roche, H., Liu, M. C., Greil, R., Ciruelos, E., Loibl, S., Gori, S., Wardley, A., Yardley, D., Brufsky, A., Blum, J

Journal:

Clinical Cancer Research

Année:

2009

Langue:

english

Fichier:

PDF, 368 KB

english, 2009

97

In England Now

Fumoleau, P., Viens, P., Dieras, V., Pujade-Lauraine, E., Espie, M., Kayitalire, L., Rongier, Anne-Marie, Pouillart, P.

Journal:

Année:

1972

Langue:

english

Fichier:

PDF, 163 KB

english, 1972

98

THE WHITEHALL RECRUITING CASE.

Fumoleau, P., Viens, P., Dieras, V., Pujade-Lauraine, E., Espie, M., Kayitalire, L., Rongier, Anne-Marie, Pouillart, P.

Journal:

Année:

1917

Langue:

english

Fichier:

PDF, 179 KB

english, 1917

99

Gemzar® (G) and epirubicin (E) in patients (pts) with metastatic breast cancer (MBC): Final results of a phase I dose finding study

Fumoleau, P., Viens, P., Dieras, V., Pujade-Lauraine, E., Espie, M., Kayitalire, L., Rongier, Anne-Marie, Pouillart, P.

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 130 KB

english, 1999

100

15 Use of a geriatric assessment questionnaire for older patients in an oncology clinic. Descriptive study of 105 patients at the Institut Curie, a French cancer treatment center

Girre, V., Gridel, G., Mosseri, V., Gisselbrecht, M., Bouleuc, C., Laki, F., Poinsot, R., Ollivier, L., Pierga, J.Y., Diéras, V., Mignot, L.

Journal:

Critical Reviews in Oncology/Hematology

Année:

2006

Langue:

english

Fichier:

PDF, 46 KB

english, 2006